Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

NCT03777982 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped PI is terminating the study due to slow/low accrual

Conditions

Prostate Cancer

Interventions

DRUG: Prednisone
DRUG: Apalutamide
DRUG: Abiraterone Acetate
DRUG: LHRH Agonist or Antagonist

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]